50-168-58

CD7 Monoclonal Antibody (eBio124-1D1 (124-1D1)), Alexa Fluor™ 700, eBioscience™, Invitrogen™

Manufacturer: Invitrogen

Select a Size

Pack Size SKU Availability Price
Each of 1 50-168-58-Each-of-1 In Stock ₹ 30,082.00

50-168-58 - Each of 1

₹ 30,082.00

In Stock

Quantity

1

Base Price: ₹ 30,082.00

GST (18%): ₹ 5,414.76

Total Price: ₹ 35,496.76

Antigen

CD7

Classification

Monoclonal

Concentration

5 μL/Test

Formulation

PBS with 0.2% BSA and 0.09% sodium azide; pH 7.2

Gene Accession No.

P09564

Gene Symbols

CD7

Purification Method

Affinity chromatography

Regulatory Status

RUO

Gene ID (Entrez)

924

Content And Storage

4° C, store in dark, DO NOT FREEZE!

Form

Liquid

Applications

Flow Cytometry

Clone

eBio124-1D1 (124-1D1)

Conjugate

Alexa Fluor 700

Gene

CD7

Gene Alias

Cd7; CD7 antigen; CD7 antigen (p41); Cd7 molecule; GP40; LEU-9; p41 protein; T-cell antigen CD7; T-cell leukemia antigen; T-cell surface antigen Leu-9; Tp40; TP41

Host Species

Mouse

Quantity

100 Tests

Primary or Secondary

Primary

Target Species

Human

Product Type

Antibody

Isotype

IgG1 κ

Related Products

Img

Invitrogen

58-007-942

--

Img

Invitrogen

50-168-77

--

Img

Invitrogen

53-019-842

--

Img

Invitrogen

64019942

--

Img

Invitrogen

62-019-842

--

Img

Invitrogen

56-083-942

--

Img

Invitrogen

63-019-382

--

Img

Invitrogen

50-168-85

--

Description

  • Description: The eBio124-1D1 monoclonal antibody reacts with human CD7, also known as gp40 and Leu9
  • CD7, a 40 kD receptor, is a member of the immunoglobulin gene superfamily
  • The N-terminal amino acid sequence (aa1-107) is highly homologous to Ig kappa light chain sequence; while the carboxyl-terminal region of the extracellular domain is proline-rich and has been postulated to form a stalk from which the Ig domain projects
  • CD7 is expressed on the majority of immature and mature T lymphocytes, and T cell leukemias
  • It is also found on natural killer cells, a small suppopulation of normal B cells and on maligant B cells
  • Cross-linking surface CD7 positively modulates T cell and NK cell activity, as measured by calcium flux, expression of adhesion molecules, cytokine secretion and proliferation
  • CD7 associates directly with phosphoinositol 3'-kinase
  • CD7 ligation induces production of D-3 phosphoinositides and tyrosine phosphorylation
  • A clonogenic subpopulation of human CD34(+) CD38(-) cord blood cells that express CD45RA and HLA-DR and high levels of the CD7 has been reported
  • These cells possess the capacity for lymphopoiesis
  • They can generate B-cells, natural killer cells, and dendritic cells but do not possess the capacity to develop into myeloid cells or erythroid cells
  • The CD7(+) phenotype distinguishes primitive human lymphoid progenitors from pluripotent stem cells
  • CD7 (gp40, Leu9) is a 40 kDa member of the immunoglobulin gene superfamily
  • CD7 contains N-terminal amino acids 1-107 are highly homologous to Ig kappa-L chains whereas the carboxy-terminal region of the extracellular domain is proline-rich and has been postulated to form a stalk from which the Ig domain projects
  • CD7 is expressed on the majority of immature and mature T-lymphocytes, and T cell leukemia
  • Further, CD7 is also found on natural killer cells, a small subpopulation of normal B cells and on malignant B cells
  • Cross-linking surface CD7 positively modulates T cell and NK cell activity as measured by calcium fluxes, expression of adhesion molecules, cytokine secretion and proliferation
  • CD7 associates directly with phosphoinositol 3'-kinase
  • CD7 ligation induces production of D-3 phosphoinositides and tyrosine phosphorylation
  • Expression of CD7 is an important marker used in leukemia diagnostics.